It has been suggested that anti‐PD‐1/PD‐L1 treatments bolster Th1 cell proliferation while concurrently attenuating Th2‐associated cytokine production, which collectively inhibits tumour growth.15, 23. The gene discussed is CD274; the disease is neoplasm.